SAN

83.29

-0.37%↓

MRK1

110.9

-0.36%↓

SHL.DE

46.1

-0.88%↓

ARGX

490.5

-0.06%↓

FRE

40.89

-0.58%↓

SAN

83.29

-0.37%↓

MRK1

110.9

-0.36%↓

SHL.DE

46.1

-0.88%↓

ARGX

490.5

-0.06%↓

FRE

40.89

-0.58%↓

SAN

83.29

-0.37%↓

MRK1

110.9

-0.36%↓

SHL.DE

46.1

-0.88%↓

ARGX

490.5

-0.06%↓

FRE

40.89

-0.58%↓

SAN

83.29

-0.37%↓

MRK1

110.9

-0.36%↓

SHL.DE

46.1

-0.88%↓

ARGX

490.5

-0.06%↓

FRE

40.89

-0.58%↓

SAN

83.29

-0.37%↓

MRK1

110.9

-0.36%↓

SHL.DE

46.1

-0.88%↓

ARGX

490.5

-0.06%↓

FRE

40.89

-0.58%↓

Search

EssilorLuxottica SA

Închisă

SectorSănătate

243.1 -0.29

Rezumat

Modificarea prețului

24h

Curent

Minim

242.9

Maxim

243.6

Indicatori cheie

By Trading Economics

Venit

993M

Vânzări

13B

P/E

Medie Sector

47.432

39.857

Randament dividend

1.7

Marjă de profit

7.512

Angajați

153,498

EBITDA

3.6B

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+9.78% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

1.70%

2.42%

Următoarele câștiguri

28 iul. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-8.8B

112B

Deschiderea anterioară

243.39

Închiderea anterioară

243.1

Sentimentul știrilor

By Acuity

37%

63%

119 / 376 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Strong Bearish Evidence

EssilorLuxottica SA Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

9 iul. 2025, 06:54 UTC

Achiziții, Fuziuni, Preluări

Meta Bought Minority Stake in Ray-Ban Maker EssilorLuxottica, Bloomberg Says, Citing Sources

30 mai 2025, 06:42 UTC

Achiziții, Fuziuni, Preluări

Ray-Ban Maker EssilorLuxottica to Buy Optegra in Medical AI Push

23 apr. 2025, 18:17 UTC

Câștiguri

Ray-Ban Maker EssilorLuxottica Implements Measures to Weather U.S. Tariffs -- Update

23 apr. 2025, 16:36 UTC

Câștiguri

Ray-Ban Maker EssilorLuxottica to Implement Measures to Mitigate U.S. Tariffs

11 iul. 2025, 10:36 UTC

Market Talk

Luxury Sector Unlikely to Report Positive Prints -- Market Talk

9 iul. 2025, 14:31 UTC

Achiziții, Fuziuni, Preluări

Meta Has Surged on the Back of AI Software. Why Hardware Is the Next Play. -- Barrons.com

9 iul. 2025, 12:25 UTC

Achiziții, Fuziuni, Preluări

Meta Wants to Reboot the Metaverse. Why AI Glasses Could Hold the Key. -- Barrons.com

9 iul. 2025, 07:21 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Meta's Reported EssilorLuxottica Investment Seen as Vote of Confidence -- Market Talk

2 iul. 2025, 15:08 UTC

Market Talk

Luxury Sector Should Report a Slowdown -- Market Talk

1 iul. 2025, 11:26 UTC

Market Talk

Luxury Sector Expected to Remain Subdued -- Market Talk

1 iul. 2025, 11:12 UTC

Market Talk

Luxury Industry Faces Deceleration as Tourism Slows -- Market Talk

30 iun. 2025, 12:07 UTC

Market Talk

EssilorLuxottica Expected to Report Growth Across All Regions -- Market Talk

5 iun. 2025, 06:04 UTC

Achiziții, Fuziuni, Preluări

EssilorLuxottica Doesn't Release Financial Details

5 iun. 2025, 06:03 UTC

Achiziții, Fuziuni, Preluări

EssilorLuxottica: Transaction Is Expected to Close by the End of June

5 iun. 2025, 06:03 UTC

Achiziții, Fuziuni, Preluări

EssilorLuxottica: A-Look Operates Over 90 Stores Under A-Look, Seen and OWL Banners

5 iun. 2025, 06:02 UTC

Achiziții, Fuziuni, Preluări

EssilorLuxottica: Deal Aimed Complementing Long-Standing Position in Malaysia

5 iun. 2025, 06:00 UTC

Achiziții, Fuziuni, Preluări

EssilorLuxottica to Buy A-Look, Seen and OWL Retail Stores in Malaysia

30 mai 2025, 08:58 UTC

Acțiuni populare

Stocks to Watch Friday: Dell, Marvell, Gap, Ulta -- WSJ

30 mai 2025, 06:04 UTC

Achiziții, Fuziuni, Preluări

EssilorLuxottica: Deal to Close in 2025 Pending Approvals, Customary Closing Conditions

30 mai 2025, 06:03 UTC

Achiziții, Fuziuni, Preluări

EssilorLuxottica Doesn't Disclose Financial Details

30 mai 2025, 06:02 UTC

Achiziții, Fuziuni, Preluări

EssilorLuxottica: Acquisition Is Part of Med-Tech Strategy

30 mai 2025, 06:01 UTC

Achiziții, Fuziuni, Preluări

EssilorLuxottica to Buy Ophthalmology Platform Optegra Clinics

30 mai 2025, 06:00 UTC

Achiziții, Fuziuni, Preluări

EssilorLuxottica to Buy Optegra Clinics

24 apr. 2025, 09:58 UTC

Market Talk
Câștiguri

EssilorLuxottica's Main Challenge Is Trade Environment -- Market Talk

24 apr. 2025, 09:35 UTC

Market Talk
Câștiguri

EssilorLuxottica's Results Show Resilience Given Macroeconomic Woes -- Market Talk

24 apr. 2025, 08:11 UTC

Market Talk
Câștiguri

EssilorLuxottica Shows Resilience, But Market Might Turn Cautious -- Market Talk

3 apr. 2025, 08:00 UTC

Market Talk

European Luxury Companies Fall After Tariffs; Profit Margins Expected to Shrink -- Market Talk

28 mar. 2025, 08:57 UTC

Market Talk

EssilorLuxottica Should Be Able to Cope With U.S. Volatility -- Market Talk

13 feb. 2025, 11:05 UTC

Market Talk
Câștiguri

EssilorLuxottica Seems Poised to Ride the Technology Wave -- Market Talk

13 feb. 2025, 10:54 UTC

Market Talk
Câștiguri

EssilorLuxottica's Midterm Margin Target Seems Challenging -- Market Talk

Comparație

Modificare preț

EssilorLuxottica SA Așteptări

Obiectiv de preț

By TipRanks

9.78% sus

Prognoză pe 12 luni

Medie 268.09 EUR  9.78%

Maxim 300 EUR

Minim 240 EUR

În baza a 12 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruEssilorLuxottica SA - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

12 ratings

7

Cumpărare

5

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

243.3 / 250.9Suport & Rezistență

Termen scurt

Strong Bearish Evidence

Termen mediu

Bearish Evidence

Termen lung

No Evidence

Sentiment

By Acuity

119 / 376 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre EssilorLuxottica SA

EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and North America. It operates through Professional Solutions and Direct to Consumer segments. The company offers lens under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, iWear, Humanware, and Optifog brands. It also provides finishing equipment, vision performance screening, eye examination and refractions, fitting parameter measurements, and small tools and consumables under the Essilor Instruments brand; high-tech equipment for optical surfacing, polishing, measuring, coating, and finishing, as well as consumables, tools, and services under the Satisloh brand. In addition, the company provides eyewear products under the Ray-Ban, Oakley, Persol, Oliver Peoples, Vogue Eyewear, Arnette, Alain Mikli, Costa, Bliz, Native, Luxottica, Sferoflex, Bolon, Molsion, DbyD, and Unofficial and Seen, as well as other Licensed brands. In addition, the company designs, develops, markets, and maintains lens edging and mounting instruments for opticians and prescription laboratories; and optometry instruments for eyecare professionals, schools, occupational medicine centers, military, and other institutions. It wholesales its products to independent opticians, distributors, third-party e-commerce platforms, and large retail chains in the eyecare and eyewear industry; and sells directly to consumers through the network of brick and mortar retail network and its online channels. The company was formerly known as Essilor International Société Anonyme and changed its name to EssilorLuxottica Société anonyme in October 2018. EssilorLuxottica Société anonyme was founded in 1849 and is headquartered in Paris, France.